NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









arcoris bio

arcoris bio

Private
SchlierenHealthcare & Life Scienceshttps://arcorisbio.com/

Last Round

Seed

Nov 6, 2025

Total Funding Raised

$7.79M

Company Overview

arcoris bio is a life science research tools and in vitro diagnostics company that develops a nanotechnology platform for biomarker detection and signal amplification to enable simultaneous detection of multiple biomarkers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryspatial multiomicsbiotech R&Ddrug developmentbiomarker detectionmultiplex immunofluorescencelife science toolsspatial biologybiopharmatherapeutic moleculeslab reagentspreclinical developmentwet-lab reagentsdiagnostic kits

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

arcoris bio Comparables

Compare arcoris bio with similar companies based on industry and business-model similarity.

arcoris bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Navignostics AG
61%
Spatomics
44%
Amplifold
44%

arcoris bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 6, 2025

Key People

Founding team and executive leadership

Matyas Vegh

CEO

Executive Team

arcoris bio Investors

Notable investors and investment history

arcoris bio investors
InvestorRounds
Ventura AceSeed
Zurcher KantonalbankSeed
ZEISS VenturesSeed
VenturaSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 14, 2024

    Monthly visitors increased 1210% MoM, from 61 to 799.

arcoris bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

arcoris bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about arcoris bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSchlieren
Employee Range13
Year Founded2022
Last FundingNov 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.